What is the lead time for bulk orders?

During peak season, the lead time is one month. During off-season, it is within 15 workdays.

Medical Balloon Inflation Device 20ml 25ml

Name: Medical Balloon Inflation Device 20ml 25ml
Brand: Qingdao Aost Medical Manufacture Co., Ltd.
SKU: 701297302

Shandong, ChinaQingdao Aost Medical Manufacture Co., Ltd.

US$1.00-10.00

1,000 Pieces

Product profile

Customization

Available

Code

Sc-Qkyl001

Sample

20USD

Model NO.

SC-QKYL001

Deliver Date

10days

OEM

Yes

Transport Package

Carton

Specification

20ml

Trademark

sure care

Origin

China

HS Code

9018

Production Capacity

100000

Key features

Accurate Pressure Control: Ensures stable performance for precise medical procedures.

ETO Sterile: Product is sterilized using Ethylene Oxide for safety.

Complete Set Packaging: Includes inflation device, high pressure stopcock, and hemostasis valve set.

OEM Service Available: Original Equipment Manufacturer customization is supported.

Fast Delivery: Sample delivery within 10 days.

Versatile Application: Suitable for Anesthesiology, ICU, and Interventional Radiology departments.

Company profile

Importers and ExportersFast DeliveryCustomization from Designs

Qingdao Aost Medical Manufacture Co., Ltd.

Shandong, China

Business Type: Manufacturer/FactoryExport Year: 2001-02-08Nearest Port: qingdaoAverage Response Time: ≤10.41hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, FCA, EXW

AI-Powered supplier vetting

SummaryQingdao Aost Medical Manufacture Co., Ltd. is identified as a Chinese manufacturer/factory and foreign joint venture operating in health and medicine and chemicals. Its stated activities include medical distribution, product and process quality management, electronic and mechanical equipment sales, technical glass manufacturing, and related product categories. The supplier offers design-based customization and reports that 90% of total sales are exports, with four years of export experience and self-operated import/export rights. However, the provided information shows no new products launched in the past year, unknown raw-material traceability, no overseas showroom, agents, branches, or offline trade-show participation, and insufficient evidence to assess financial strength or customer cases. An audit by TUV Rheinland is documented for the period from February 28, 2025 to February 27, 2026, but the audit result is recorded as 0 without an explanatory interpretation.

Supplier typeThe supplier is explicitly identified as a Manufacturer/Factory located in Qingdao, Shandong, China, and is organized as a foreign joint venture. Its stated commercial sectors include Health & Medicine and Chemicals, consistent with its medical manufacturing positioning.

After-Sales capabilityThe company states that it provides sales and service activities specialized in the medical field. At the same time, it reports no overseas showroom, overseas agents or branches, overseas service countries, or offline trade-show participation, indicating limited documented overseas service infrastructure.

R&D capabilityThe supplier explicitly reports no new products launched during the past year. Although it offers customization from designs, the available evidence does not demonstrate recent product innovation or development output.

Production capacityThe supplier is identified as a manufacturer and reports quality assurance and process/product control activities. Its listed scope includes technical glass manufacturing and sales of medical, electronic, mechanical, rubber, chemical, packaging, and related products, supporting broad production and product-handling capability, though no capacity, equipment, workforce, or output figures are provided.

Customization capabilityThe supplier explicitly states “Customization from Designs,” which directly supports an ability to provide design-based customization. No further information is provided on engineering resources, minimum quantities, tooling, or customization limits.